- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06567964
Ultrasound-guided ESP Block vs. Wound Infiltration in Lumbar Surgery: A Comparative Analysis (ESP:Erector Spinae Plane) (ESP)
Comparative Efficacy of Ultrasound-guided Erector Spinae Plane Block Versus Wound Infiltration for Postoperative Analgesia in Instrumented Lumbar Spinal Surgeries
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Saglik Bilimleri Universitesi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Elective lumbar spine surgery involving instrumentation
- ASA physical status I-III
- Ability to provide informed consent
Exclusion Criteria:
- Known allergies to local anesthetics
- Coagulopathy or anticoagulant therapy
- Infection at the injection site
- Preexisting neurological disorders affecting sensory perception
- Pregnancy
- Inability to understand the visual analog scale (VAS) for pain assessment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Erector Spinae Plane Block (Group E)
ESPB was administered preoperatively under ultrasound guidance via a high-frequency linear probe (Sonosite M-Turbo, Fujifilm Sonosite Inc., USA) (Figure 1). The procedure was as follows:
|
ESPB was administered preoperatively under ultrasound guidance via a high-frequency linear probe (Sonosite M-Turbo, Fujifilm Sonosite Inc., USA) (Figure 1). The procedure was as follows:
|
|
Active Comparator: Wound infiltration (Group WI)
Wound infiltration was performed by the surgeon at the end of the surgery via the following procedure:
|
Wound infiltration was performed by the surgeon at the end of the surgery via the following procedure:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative pain intensity
Time Frame: 1., 6., 12., 24., and 48. hours postoperatively
|
The pain intensity was assessed via the visual analog scale (VAS).The VAS is a 10 cm scale ranging from 0 (no pain) to 10 (worst imaginable pain).
|
1., 6., 12., 24., and 48. hours postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Opioid Consumption
Time Frame: In the first 48 hours postoperatively
|
Recorded as morphine equivalents
|
In the first 48 hours postoperatively
|
|
Time to first request for rescue analgesia
Time Frame: Noted in hours in the first 48 hours postoperatively
|
Noted in hours postoperatively
|
Noted in hours in the first 48 hours postoperatively
|
|
Incidence of Side Effects
Time Frame: Recorded as binary outcomes (present/absent) in the first 48 hours postoperatively
|
Including nausea, vomiting, pruritus, and urinary retention,
|
Recorded as binary outcomes (present/absent) in the first 48 hours postoperatively
|
|
Patient Satisfaction with Pain Management
Time Frame: At 48 hours postoperatively
|
Patient satisfaction was assessed via a 5-point Likert scale (1 = very dissatisfied, 5 = very satisfied)
|
At 48 hours postoperatively
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yücel Yüce, MD,Assoc Prf, Saglik Bilimleri Universitesi
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SaglikBilimleriU-KLKSH-Anes-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.